25 related articles for article (PubMed ID: 21176871)
1. Immunohistochemical FAP Expression Reflects
Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
[TBL] [Abstract][Full Text] [Related]
2. Using CADD tools to inhibit the overexpressed genes FAP, FN1, and MMP1 by repurposing ginsenoside C and Rg1 as a treatment for oral cancer.
Abouelwafa M; Ibrahim TM; El-Hadidi MS; Mahnashi MH; Owaidah AY; Saeedi NH; Attia HG; Georrge JJ; Mostafa A
Front Mol Biosci; 2023; 10():1248885. PubMed ID: 37936719
[TBL] [Abstract][Full Text] [Related]
3. The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma.
Li K; Zeng X; Liu P; Zeng X; Lv J; Qiu S; Zhang P
J Inflamm Res; 2023; 16():4301-4315. PubMed ID: 37791117
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Bisheshar SK; De Ruiter EJ; Devriese LA; Willems SM
Oncoimmunology; 2020; 9(1):1747345. PubMed ID: 32363116
[No Abstract] [Full Text] [Related]
5. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
6. NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.
Wu D; Wu P; Zhao L; Huang L; Zhang Z; Zhao S; Huang J
Medicine (Baltimore); 2015 Oct; 94(40):e1687. PubMed ID: 26448015
[TBL] [Abstract][Full Text] [Related]
7. 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma.
Wang W; Wang J; Li M; Ying J; Jing H
Int J Mol Med; 2015 Sep; 36(3):698-704. PubMed ID: 26133246
[TBL] [Abstract][Full Text] [Related]
8. Applicability of preoperative nuclear morphometry to evaluating risk for cervical lymph node metastasis in oral squamous cell carcinoma.
Karino M; Nakatani E; Hideshima K; Nariai Y; Tsunematsu K; Ohira K; Kanno T; Asahina I; Kagimura T; Sekine J
PLoS One; 2014; 9(12):e116452. PubMed ID: 25549090
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations of protein tyrosine phosphatases in human cancers.
Zhao S; Sedwick D; Wang Z
Oncogene; 2015 Jul; 34(30):3885-94. PubMed ID: 25263441
[TBL] [Abstract][Full Text] [Related]
10. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-KappaB as a common target and activator of oncogenes in head and neck squamous cell carcinoma.
Chang AA; Van Waes C
Adv Otorhinolaryngol; 2005; 62():92-102. PubMed ID: 15608421
[TBL] [Abstract][Full Text] [Related]
12. FAP-1 and NF-κB expressions in oral squamous cell carcinoma as potential markers for chemo-radio sensitivity and prognosis.
Nariai Y; Mishima K; Yoshimura Y; Sekine J
Int J Oral Maxillofac Surg; 2011 Apr; 40(4):419-26. PubMed ID: 21176871
[TBL] [Abstract][Full Text] [Related]
13. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
15. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
